Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Integrative Transfer Network: Deep Transfer Learning Across Populations and Prediction Targets.

bioRxiv : the preprint server for biology·2026
Same author

Epigenetic entropy, socioeconomic differences, and health and lifespan in the Women's Health Initiative.

Clinical epigenetics·2026
Same author

Omics-based Cancer Prognosis Across Ethnic Groups: From Feature Engineering to Disparity Detection and Mitigation.

IEEE transactions on artificial intelligence·2026
Same author

Bridging Ancestry Gaps in Genomic Risk Prediction with Tabular Foundation Models.

bioRxiv : the preprint server for biology·2026
Same author

Data Representation Bias and Conditional Distribution Shift Drive Predictive Performance Disparities in Multi-Population Machine Learning.

bioRxiv : the preprint server for biology·2026
Same author

Survival and Quality of Life After Reirradiation With Concurrent Pemetrexed/Erlotinib Followed by Maintenance Erlotinib for Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma: Final Report of a Phase I/II Trial.

Cureus·2026
Same journal

Layered social competition coordinates reproductive hierarchy formation in ants.

bioRxiv : the preprint server for biology·2026
Same journal

Combination epigenetic-targeted therapy increases the immunogenicity of poorly immunogenic sarcomas.

bioRxiv : the preprint server for biology·2026
Same journal

Loss of LanC-like proteins delays post-injury regeneration of aging skeletal muscles.

bioRxiv : the preprint server for biology·2026
Same journal

Confidence-supported label-free metabolic imaging with FPhaS phase autofluorescence microscopy.

bioRxiv : the preprint server for biology·2026
Same journal

Sequence-encoded autoinhibition couples mRNA decapping activity to phase separation.

bioRxiv : the preprint server for biology·2026
See all related articles

Related Experiment Video

Updated: Jun 13, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Equitable Health Intelligence: An Open Benchmark of Multi-Population Machine Learning for Omics-Based Cancer

Teena Sharma, Aarat Prasad Chopra, Laxita Agrawal

    Biorxiv : the Preprint Server for Biology
    |June 12, 2026
    PubMed
    Summary
    This summary is machine-generated.

    Equitable Health Intelligence (EHI) is a new benchmark to detect and fix biased machine learning (ML) predictions in cancer prognosis across diverse populations. EHI promotes equitable genomic medicine by addressing performance disparities in omics-based cancer research.

    Related Experiment Videos

    Last Updated: Jun 13, 2026

    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
    07:41

    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

    Published on: May 17, 2019

    Area of Science:

    • Biomedical informatics
    • Genomic medicine
    • Artificial intelligence in oncology

    Background:

    • Machine learning (ML) models for omics-based cancer prognosis often exhibit performance disparities across different ancestral populations due to training data biases.
    • Existing fairness benchmarks primarily focus on outcome parity, neglecting predictive performance parity, which is crucial for equitable healthcare.
    • There is a critical need for public benchmark resources to systematically identify and mitigate performance disparities in multi-population cancer prognosis ML models.

    Purpose of the Study:

    • To develop an open-source benchmark, Equitable Health Intelligence (EHI), for evaluating multi-population machine learning models in omics-based cancer prognosis.
    • To provide a platform for systematically detecting and addressing performance disparities between majority and data-disadvantaged populations in cancer prognosis models.
    • To facilitate the development of equitable AI solutions in precision oncology by addressing biomedical data inequality.

    Main Methods:

    • Developed Equitable Health Intelligence (EHI), an open-source benchmark comprising 1,475 ML tasks across 40 cancer types, 4 omics feature sets, and 3 data-disadvantaged population groups.
    • Trained deep neural network models using three multi-population ML schemes (Mixture, Independent, Transfer Learning) and a Naive Transfer control, totaling 10,325 ML experiments.
    • Included interactive visualization and exploratory tools for inspecting performance disparities and evaluating mitigation strategies.

    Main Results:

    • The EHI platform enables users to inspect predictive performance disparities between European-ancestry and data-disadvantaged populations.
    • Users can evaluate the effectiveness of transfer learning in mitigating performance disparities across various cancer types, omics features, and clinical endpoints.
    • The benchmark facilitates the examination of feature engineering impacts on model performance across diverse populations.

    Conclusions:

    • EHI serves as an open, interactive, and extensible benchmark for identifying and addressing performance disparities in multi-population ML for omics-based cancer prognosis.
    • It provides a foundation for developing methods to mitigate ML performance disparities stemming from data inequality and population shifts.
    • EHI advances equitable AI in precision oncology by promoting fairness and improving predictive accuracy for all populations.